ArticleJournal of biomedical physics & engineering2025
Detection and Classification of Lesions in Mammograms using One-Stage Models.
Article in Journal of biomedical physics & engineering, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Breast cancer, the most common cancer among women, necessitates early detection. Despite advances in Computer-Aided Diagnosis (CAD), lesion detection in mammograms remains challenging. Artificial Intelligence (AI) in radiology offers significant potential to enhance diagnostic accuracy in medical imaging. Objective: This study compares object detection methods to identify the most effective model for smart diagnostic systems. This comprehensive study is the first to apply the advanced You Only Look Once version 12 (YOLO-v12) architecture for the automated detection and localization of lesions in mammographic images and to identify their malignancy or benignity status with high precision. Material and Methods: This comparative experimental study, utilizing retrospective data, also evaluated two state-of-the-art models, the Detection Transformer (DETR) and RetinaNet, for their performance. The models were trained and tested on the publicly available Categorized Digital Database for Low-Energy and Subtracted Contrast-Enhanced Spectral Mammography (CDD-CESM), which contains 1,982 mammograms with 3,720 annotated lesions of various types and sizes. Results: YOLO-v12 demonstrated excellent diagnostic accuracy (mean Average Precision at an IOU threshold of 0.5 (mAP50)=0.98; Intersection Over Union (IOU)=0.95), significantly outperforming contemporary models and older YOLO versions. Conclusion: The promising and robust results clearly underscore the remarkable potential of artificial intelligence technologies in effectively assisting radiologists with the early detection and diagnosis of breast cancer. These findings advocate for the implementation of YOLO-v12 in clinical mammography screening applications and suggest that future research should prioritize real-time diagnostic systems to further enhance breast cancer detection capabilities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.